CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Lignende værker

• Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
  af: Niikura, Naoki, et al.
  Udgivet: (2012)
• Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer
  af: Alvarez, Ricardo H., et al.
  Udgivet: (2013)
• The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
  af: Hsu, Jennifer L., et al.
  Udgivet: (2016)
• Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family
  af: Wang, Ying-Nai, et al.
  Udgivet: (2012)
• Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification
  af: Shin, Daniel Sanghoon, et al.
  Udgivet: (2016)